(Q37159660)

18 August 2017

Vesnarinone represses the fibrotic changes in murine lung injury induced by bleomycin (English)

1 reference

18 August 2017

1 reference

Minoru Inage

1

1 reference

18 August 2017

Hidenori Nakamura

2

1 reference

18 August 2017

Hiroshi Saito

3

1 reference

18 August 2017

Shuichi Abe

4

1 reference

18 August 2017

Toshihiko Hino

5

1 reference

18 August 2017

Noriaki Takabatake

6

1 reference

18 August 2017

Kyoko Terashita

7

1 reference

18 August 2017

Manabu Ogura

8

1 reference

18 August 2017

Shuichi Kato

9

1 reference

18 August 2017

Tetsumi Hosokawa

10

1 reference

18 August 2017

Makoto Sata

11

1 reference

18 August 2017

Hitonobu Tomoike

12

1 reference

18 August 2017

language of work or name

English

0 references

publication date

16 April 2009

1 reference

International Journal of Biological Sciences

18 August 2017

1 reference

18 August 2017

5

1 reference

18 August 2017

4

1 reference

18 August 2017

304-310

1 reference

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Histologic spectrum of idiopathic interstitial pneumonias

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Simple method of estimating severity of pulmonary fibrosis on a numerical scale

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Inhibition of hyaluronan synthesis by vesnarinone in cultured human myofibroblasts

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Hydrogen peroxide enhances shedding of type I soluble tumor necrosis factor receptor from pulmonary epithelial cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Vesnarinone: a potential cytokine inhibitor

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Tumour necrosis factor receptor gene expression and shedding in human whole lung tissue and pulmonary epithelium

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Vesnarinone inhibits induction of nitric oxide synthase in J774 macrophages and rat cardiac myocytes in culture

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Vesnarinone and amrinone reduce the systemic inflammatory response syndrome.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Histochemical evaluation of lung collagen content in acute and chronic interstitial diseases.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Subclinical idiopathic pulmonary fibrosis is also a risk factor of postoperative acute respiratory distress syndrome following thoracic surgery.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669598

Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice

3 September 2018

1 reference

12 December 2020

Vesnarinone prolongs action potential duration without reverse frequency dependence in rabbit ventricular muscle by blocking the delayed rectifier K+ current

1 reference

12 December 2020

Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4

1 reference

12 December 2020

The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid

1 reference

12 December 2020

Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis

1 reference

12 December 2020

Pharmacokinetics of a new positive inotropic agent, 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), in the rat, rabbit, beagle dog and rhesus monkey

1 reference

12 December 2020

Effects of vitamin E deficiency on bleomycin-induced pulmonary fibrosis in the hamster

1 reference

12 December 2020

Pharmacokinetic profile of OPC-8212 in humans: a new, nonglycosidic, inotropic agent

1 reference

12 December 2020

Ca2+(-)dependent and Ca2+(-)independent vasorelaxation induced by cardiotonic phosphodiesterase inhibitors

1 reference

12 December 2020

Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure

1 reference

12 December 2020

The Bradford method for protein quantitation

1 reference

12 December 2020

Vesnarinone prolongs survival and reduces lethality in a murine model of lethal endotoxemia

1 reference

12 December 2020

Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients

1 reference

12 December 2020

Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbilical vein endothelial cells

1 reference

12 December 2020

Inhibition of CD4 cross-linking-induced lymphocytes apoptosis by vesnarinone as a novel immunomodulating agent: vesnarinone inhibits Fas expression and apoptosis by blocking cytokine secretion

1 reference

12 December 2020

Identifiers

DOI

10.7150/IJBS.5.304

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19381349

1 reference